Health infrastructure in Côte d’Ivoire remains weak and unevenly distributed as a result of insufficient investment and the damage borne throughout a decade of conflict. This has had a negative impact on access to health services, making it difficult for health care agents to adequately satisfy the population’s needs. Boosting investment in...
Côte d’Ivoire is a member of the West African Pharmaceutical Manufacturers Association (WAPMA), comprising ECOWAS and EMOA member states that total 15 countries and a population of about 340m people. The country stands with Senegal today at the forefront of pharmaceuticals production in the French-speaking West African world, while Ghana and...
What are some of the challenges facing the universal health care system in Côte d’Ivoire?
Côte d’Ivoire is investing in achieving sustainable high growth levels, for which it requires a strong education sector. The government has its eyes set on expanding basic education access, improving education quality and governance, and enhancing the link between education and the job market. Despite efforts carried out in recent years, there...
With its sights set on achieving emerging nation status by 2020, Côte d’Ivoire is looking to strengthen its technical and vocational training capacity to better respond to its evolving labour market needs.
Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.
Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.
Register Here×